The American Cancer Society struck a multi-year collaboration with Layer Health, a healthcare AI company that uses LLMs to improve data abstraction and generate insights. The partners will abstract data from thousands of medical charts of patients enrolled in the American Cancer Society's research studies, with the ultimate goal of shortening research timelines.
AstraZeneca's EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases. EsoBiotec's allogeneic cell therapies are made by the in vivo reprogramming of a patient's immune cells.
The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they're far from perfect.
Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented.
Abarca Chief Growth and Commercial Officer Javier Gonzalez explained how PBMs can adopt new specialty drug pricing models, as well as how they can develop digital programs that help tackle the obesity crisis.
Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost.
In this episode, we're joined by Pam Pure, co-founder and CEO of Posterity Health, and Khaled Kteily, founder and CEO of Legacy. They discuss why we should view infertility as a men's issue as well as a women's issue.
No comments